期刊文献+

真核表达载体pcDNA3.1-RASSF1的构建及其对肝癌细胞凋亡的影响

The construction of pcDNA 3.1 RASSF1 eukaryotic vector and the influence of RASSF1 on apoptosis of hepatocarcinoma cell line
原文传递
导出
摘要 目的构建pcDNA3.1-RASSFl真核表达载体,并检测其对肝癌细胞系HepG2凋亡的影响。方法应用聚合酶链反应技术从人RASSFlcDNA中扩增出RASSF1基因后,以内切酶XhoI和EcoRI进行双酶切,将其克隆人用相同酶处理的载体pcDNA3.1;将重组质粒pcDNA3.1-RASSF1转染肝癌HepG2细胞,应用Westernblot法检测RASSF1的表达水平;用AnnexinV/PI法检测细胞的凋亡情况。结果酶切和测序结果表明,重组质粒pcDNA3.1.RASSF1构建成功;Westernblot法结果表明转染pcDNA3.1-RASSF1后HepG2细胞中RASSFl表达升高;AnnexinV/PI法用流式细胞术检测凋亡,空白组、pcDNA3.1组和pcDNA3.1-RASSFl组HepG2细胞的凋亡率分别为(5.8±0.42)%、(7.48±0.68)%和(35.1±3.15)%。结论真核表达载体pcDNA3.1-RASSF1构建成功;RASSF1蛋白在HepG2细胞中高表达,并促进细胞凋亡。 Objective To construct pcDNA3.1 RASSF1 eukaryotic vector and observe the influence of RASSF1 on the apoptosis of hepatocarcinoma cell line HepG2. Methods RASSF1 gene was ampli- fied from human RASSF1 cDNA by polymerase chain reaction (PCR) and cloned into pcDNA3.1. The re- combinant plasmid pcDNA3.1 RASSF1 was transfected into hepatocarcinoma HepG2 cell line. The expression of RASSF1 was examined by Western blot. The influence of RASSF1 on the cell apoptosis was meas- ured by Annexin V/PI assay. Results DNA enzyme digestion and sequencing results showed that recombi- nant plasmid pcDNA3.1-RASSF1 was successfully constructed. RASSF1 protein was overexpressed in HepG2 cell line transfected with pcDNA3.1-RASSF1 plasmid. The apoptosis rate of blank, pcDNA3.1 and pcDNA3.1-RASSF1 group was (5.8 ± 0. 42) %, (7.48 ± 0.68 ) % and ( 35.1 ± 3.15 ) %, respectively. Conclusion The pcDNA3.1- RASSF1 eukaryotic vector was successfully constructed, RASSF1 protein overexpression could induce apoptosis in HepG2 cell line.
出处 《中国医师杂志》 CAS 2011年第1期16-18,22,共4页 Journal of Chinese Physician
关键词 ras蛋白质类/遗传学/代谢 肿瘤抑制蛋白质类/遗传学 遗传载体 肝肿瘤/代谢 细胞凋亡 Ras proteins/GE/ME Tumor suppressor proteins/GE Genetic vectors Liver neoplasms/ME Apoptosis
  • 相关文献

参考文献15

  • 1Comincini S,Castiglioni BM,Foti GM,et al.Isolation and molecular characterization of rasfadin,a novel gene in the vicinity of the bovine prion gene.Mamm Genome,2001,12(2):150-156.
  • 2Vos MD,Ellis CA,Elam C,et al.RASS2 is a novel K-Ras-specific effector and potential tumor suppressor.J Biol Chem,2003,278 (30):28045 -28051.
  • 3Sherwood V,Recino A,Jeffries A,et al.The N-terminal RASSF family:a new group of Ras-association-domain-containing proteins,with emerging links to cancer formation.Biochem J,2009,425(2):303-311.
  • 4Richter AM,Pfeifer GP,Dammann RH.The RASSF proteins in cancer,from epigenetic silencing to functional characterization.Biochim Biophys Acta,2009,1796(2):114-128.
  • 5黄俊辉,海健,胡铁辉.乳腺癌诊疗新进展[J].中国医师杂志,2003,5(12):1722-1724. 被引量:1
  • 6林彬.结直肠癌组织抑癌基因DCC和转移抑制基因nm23-H1蛋白表达状态的研究[J].中国医师杂志,2003,5(10):1417-1417. 被引量:1
  • 7丁波泥,陈道瑾,吴君辉,石光清,海健.乳腺癌中CA125、CA15-3的表达及其意义[J].中国医师杂志,2005,7(1):49-51. 被引量:21
  • 8van der Weyden L,Adams DJ.The Ras-association domain family (RASSF) members and their role in human tumourigenesis.Biochim Biophys Acta,2007,1776(1):58-85.
  • 9Vojtek AB,Der CJ.Increasing complexity of the Ras signaling pathway.J Biol Chem,1998,273 (32):19925-19928.
  • 10Hallberg B,Rayter SI,Downward J.Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation.J Biol Chem,1994,269(6):3913-3916.

二级参考文献67

  • 1庄小强,郑杰,林三仁,孙桂华,田野.胃癌中幽门螺杆菌感染与胃粘膜增殖及凋亡研究[J].中国人兽共患病杂志,2005,21(9):765-768. 被引量:4
  • 2Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a ras association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet, 2000,25:315-319.
  • 3Wistuba I, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res, 2000,60: 1949-1960.
  • 4Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res,1997, 71:27-92.
  • 5Hung J, Kishimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.JAMA, 1995,273 : 558-563.
  • 6Sekido Y, Ahmadian M, Wistuba II, et al. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene, 1998,16:3151-3157.
  • 7Lee MG, Kim HY, Byun DS, et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res, 2001,61:6688-6692.
  • 8Byun DS, Lee MG, Chae KS, et al. Frequent epigenetic inactivation of RASSFIA by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res, 2001, 61: 7034-7038.
  • 9Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Nat Cancer Inst, 2001,93 : 691-699.
  • 10Vos MD, Ellis CA, Bell A, et al. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem, 2000,275:35669-35672.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部